Skip to main content

Adjuvante Therapie nach radikaler Prostatektomie

  • Chapter
Aktuelle Therapie des Prostatakarzinoms
  • 21 Accesses

Zusammenfassung

Gegenwärtig fehlen wissenschaftliche Daten, um eine routinemäßige Anwendung der adjuvanten Behandlung nach radikaler Prostatektomie zu rechtfertigen. Allerdings gibt es zahlreiche zumeist retrospektive Studienergebnisse, die nach Auffassung der National Institutes of Health Consensus Development Conference (1988) Hinweise liefern, daß eine Androgendeprivation und die Bestrahlung unbedingt untersucht werden müssen. Dies gilt ebenso für die entsprechende Patientengruppe, die in einer kontrollierten Studie untersucht werden müßte. Eine prospektive, randomisierte Studie über den Wert einer adjuvanten Chemotherapie oder Estradmustin Phosphatgabe nach radikaler Prostatektomie wurde 1978 unter den Auspizien des National Prostatic Cancer Project (Protokoll 900) aktiviert (Schmidt 1984), es gelang aber den Studienkoordinatoren nicht, die aus statistischen Gründen erforderliche Zahl von Patienten bis zum Ende des Jahres 1989 zu erreichen, so daß das Protokoll 900 unvollendet blieb (Schmidt et al. 1989). Somit kann gegenwärtig hinsichtlich des Wertes einer adjuvanten Therapie nach radikaler Prostatektomie nur auf retrospektive Studien verwiesen werden. (Carter et al. 1989; Steinberg et al. 1989).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 74.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Altwein JE, Leitenberger A (1990) Adjuvant therapy following radical prostatectomy. Akt Urol (Suppl] 21: 13–17

    Article  Google Scholar 

  • Altwein JE, Leitenberger A, Ay R (1984) Wert der Computertomographie und Lymphographie zum Nachweis von pelvinen Lymphknotenmetastasen beim Prostatakarzinom. Urol Int 39: 178–183

    Article  PubMed  CAS  Google Scholar 

  • Anscher MS Prosnitz LR (1987) Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 138: 1407–1412

    PubMed  CAS  Google Scholar 

  • Bailas JC, Louis JA, Lavori PW, Polansky M (1984) Studies without internal controls. N Engl J Med 311: 156–162

    Article  Google Scholar 

  • Belt E, Schröder FH (1972) Total perineal prostatectomy for carcinoma of the prostate. J Urol 107: 91–96

    PubMed  CAS  Google Scholar 

  • Brawn P. Kuhl D, Johnson C, Pandya P, McCord R (1990) Stage D1 prostate carcinoma — the histologic appearance of nodal metastases and its relationship to survival. Cancer 65: 538–543

    Article  PubMed  CAS  Google Scholar 

  • Catalona WJ, Dresner SM (1985) Nerve-sparing radical prostatectomy: extraprostatic extension and preservation of erectile function: J Urol 134: 1149–1157

    PubMed  CAS  Google Scholar 

  • Catalona WJ, Miller DR, Kavoussi LR (1988) Intermediate-term survival results in clinically understaged prostatic cancer patients following radical prostatectomy. J Urol 140: 540–543

    PubMed  CAS  Google Scholar 

  • Carter GE, Lieskovsky G, Skinner DG, Petrovich Z (1989) Results of local and/or systemic adjuvant therapy in the management of pathological stage C on D1& prostate cancer following radical prostatectomy. J Urol 142: 1266–1271

    PubMed  CAS  Google Scholar 

  • Egelston JC, Walsh PC (1985) Radical prostatectomy with preservation of sexual function: pathological findings in the first 100 cases. J Urol 134: 1146–48

    Google Scholar 

  • Flocks RH (1973) The treatment of stage C prostate cancer with special reference to combined surgical and radiation treatment. J Urol 109: 461–463

    PubMed  CAS  Google Scholar 

  • Gervasi LA, Mata J, Easley JD, Wilbanks JH, Seale-Hawkins C, Carlton CE, Scardino PT (1989) prognostic significance of lymph nodal metastases in prostate cancer. J Urol 142: 332–336

    PubMed  CAS  Google Scholar 

  • Gibbons RP, Cole BS, Richardson RG, Correa RJ, Branen GE, Mason JT, Taylor WJ, Hafermann MD (1986) Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 135: 65–68

    PubMed  CAS  Google Scholar 

  • Golimbu M, Provet J, Al-Askari S, Morales P (1987) Radical prostatectomy for stage D1prostate cancer. Urology 30: 427–435

    Article  PubMed  CAS  Google Scholar 

  • Gross R (1990) Adjuvante oder neo-adjuvante Chemotherapie. Dtsch Ärztebl 87: 146–147

    Google Scholar 

  • Herr HW (1983) Interstitial radiotherapy for locallized cancer of the prostate. Clin Oncol 2: 407–419

    Google Scholar 

  • Kramer Sa, Cline WA, Farnham R, Carson CC, Cox EB, Hinshaw W, Paulson DA (1981) prognosis of patients with stage D1 prostatic adenocarcinoma. J Urol 125: 817–819

    PubMed  CAS  Google Scholar 

  • Lange Ph, Reddy PK, Medini E, Levitt S, Fraley EE (1988) Radiation therapy as adjuvant treatment after radical prostatectomy. NCI Monogr 7: 141–149

    PubMed  Google Scholar 

  • Link P, Freiha FS, Stamey TA (1991) Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532–534

    PubMed  CAS  Google Scholar 

  • Morgan WR, Zincke H, Rainwater LM, Myers RP, Klee GG (1991) Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: Impact of adjuvant treatment (hormonal and radiation). J Urol 145: 319–323

    PubMed  CAS  Google Scholar 

  • Myers RP, Zincke H, Fleming TR, Forrow GM, Furlow WL, Utz DC (1983) Hormonal treatment at time of radical retropubic prostatectomy for stage D1prostate cancer. J Urol 130: 99–101

    PubMed  CAS  Google Scholar 

  • National Institutes of Health Consensus Development Panel (1988) Consensus-statement — the management of clinically localized prostatic cancer. NCI Monogr 7: 3–6

    Google Scholar 

  • Paulson DF, Moul JW, Robertson JE, Walther PJ (1990) Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 143: 1178–82

    PubMed  CAS  Google Scholar 

  • Pilepich MV, Walz BJ, Baglan RJ (1984) Postoperative irradiation in carcinoma of the prostate, Int J Radiol Oncol Biol Phys 10: 1869–1873

    Article  CAS  Google Scholar 

  • Ray GR, Bagshaw MA, Freiha F (1984) External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 132: 926–930

    PubMed  CAS  Google Scholar 

  • Schellhammer PF, Whitmore RB, Kuban DA, El-Mahdi AM, Ladaga LA (1989) Morbidity and mortality of local failure after definitive therapy for prostate cancer. J Urol 143: 567–571

    Google Scholar 

  • Schmidt JD (1984) Cooperative clinical trials of the National Prostatic Cancer Project: protocol 900. Prostate 5: 387–399

    Article  PubMed  CAS  Google Scholar 

  • Steinberg GD, Epstein JI, Piantadosi S, Walsh PC (1989) Management of stage D1 adenocarcinoma of the prostate: The John Hopkins experience 1974–87. J Urol 141: 310A

    Google Scholar 

  • Tomlinson RL, Currie DP, Boyce WH (1977) Radical prostatectomy Palliation for stage C carcinoma of the prostate. J Urol 117: 85–87

    PubMed  CAS  Google Scholar 

  • Vickery Al, Kerr WS (1963) Carcinoma of prostate treated by radical prostatectomy: clinicopathologic survey of 187 cases followed for 5 years and 148 cases followed for 10 years. Cancer 16: 1598–1608

    Article  PubMed  Google Scholar 

  • Walsh PC (1987) Adjuvant radiotherapy after radical prostatectomy: is it indicated? J Urol 138: 1427–1428

    PubMed  CAS  Google Scholar 

  • Walsh PC, Epstein JI, Lowe FC (1987) Potency following radical prostatectomy with wide unilateral excision of the neurovascular bundle. J Urol 138: 823–827

    PubMed  CAS  Google Scholar 

  • Walsh PC (1988) radical retropubic prostatectomy with reduced morbidity: an anatomical approach. NCI Monogr 7: 133–137

    PubMed  Google Scholar 

  • Zincke H, Utz DC Thulé PM, Taylor WF (1987) Treatment options for patients with stage D1 (T0–3, N1–2, M0) adenocarcinoma of prostate. Urology 30: 307–315

    Article  PubMed  CAS  Google Scholar 

  • Zincke H (1989a) Radikale Prostatektomie und adjuvante Therapie beim Adenokarzinom der Prostata. In: Sommerkamp H, Altwein JE (Hrsg) Prostatakarzinom — Spektrum der kurativen Therapie. Karger, Basel, S 244–260

    Google Scholar 

  • Zincke H (1989b) Radikale Prostatektomie bei regionärem Lymphknotenbefann (D1;T0–3, N1–2, M0). In: Sommerkamp H, Altwein JE (Hrsg) Prostatakarzinom — Spektrum der kurativen Therapie. Karger, Basel, S 261–286

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Altwein, J.E., Leitenberger, A. (1991). Adjuvante Therapie nach radikaler Prostatektomie. In: Ackermann, R., Altwein, J.E., Faul, P. (eds) Aktuelle Therapie des Prostatakarzinoms. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84264-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84264-1_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84265-8

  • Online ISBN: 978-3-642-84264-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics